Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor β receptor therapy

  • Jonghwa Won
  • , Hongtae Kim
  • , Eun Jeong Park
  • , Yeonchul Hong
  • , Seong Jin Kim
  • , Yungdae Yun

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Fingerprint

Dive into the research topics of 'Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor β receptor therapy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Immunology and Microbiology